Literature DB >> 29936463

A Study of Short- and Long-term mRNA Levels of the Retn, Iapp, and Drd5 Genes in Obese Mice Induced with High-fat Diet.

Ozlem Timirci-Kahraman1, Umit Yilmaz1, Nesibe Yilmaz1, Aydin Cevik2, Cem Horozoglu1,3, Faruk Celik1, Muhammed Oguz Gokce1, Arzu Ergen1, Abdullah Melekoglu4, Umit Zeybek5.   

Abstract

BACKGROUND/AIM: Adipocyte gene expression is altered in obese individuals through multiple metabolic and biochemical pathways. In this study, we aimed to examine the expression of resistin (Retn), amylin (Iapp), and dopamine receptor domain 5 (Drd5) genes previously suggested to contribute to the pathogenesis of obesity, albeit controversially. We also aimed to determine the effects on short and long-term mRNA levels of these genes in obese mice, induced with high-fat diet (HFD).
MATERIALS AND METHODS: Two obesity models were created in our study: group T1 (20 mice) was fed with HFD (60% fat) for 3 months, and group T2 (20 mice) was fed with HFD (60% fat) for 6 months. The control group T0 (20 mice) was fed with a diet of 10% kcal fat supplement for 6 months. At the end of the experiment, their adipose tissues were dissected surgically. Tissue samples of each group were pooled for RNA isolation, cDNA synthesis was carried out and the mRNA levels were examined by quantitative real-time polymerase chain reaction. Serum resistin levels were measured using multiplex bead (luminex) technology for validation.
RESULTS: In T2 mice, the mRNA expression of Retn showed a moderate up-regulation (fold change=8.32; p=0.0019) in the adipose tissues. Iapp expression was also significantly up-regulated (fold change=9.78; p=0.012). Moreover, a 6.36-fold up-regulation for Drd5 was observed in the adipose tissues of T2 mice (p<0.001). At the same time, serum levels of resistin were found to be high in T1 and T2 mice compared to the control group (p<0.001 and p=0.024, respectively).
CONCLUSION: Our study demonstrated that the mRNA levels of the genetic markers considered to play a role in adipogenesis were different in short- and long-term obesity models formed in C57BL/6J mice using HFD. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C57BL/6J; Drd5; Gene expression; Iapp; Retn

Mesh:

Substances:

Year:  2018        PMID: 29936463      PMCID: PMC6117763          DOI: 10.21873/invivo.11312

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications.

Authors:  Jonathan D Roth; Holly Maier; Steve Chen; Barbara L Roland
Journal:  Arch Neurol       Date:  2009-03

3.  Resistin, central obesity, and type 2 diabetes.

Authors:  C L McTernan; P G McTernan; A L Harte; P L Levick; A H Barnett; S Kumar
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

4.  Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.

Authors:  Jonathan D Roth; Heather Hughes; Eric Kendall; Alain D Baron; Christen M Anderson
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

5.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Authors:  Joan Vendrell; Montserrat Broch; Nuria Vilarrasa; Ana Molina; Jose Manuel Gómez; Cristina Gutiérrez; Immaculada Simón; Joan Soler; Cristóbal Richart
Journal:  Obes Res       Date:  2004-06

6.  Serum resistin (FIZZ3) protein is increased in obese humans.

Authors:  Mikako Degawa-Yamauchi; Jason E Bovenkerk; Beth Elisa Juliar; William Watson; Kimberly Kerr; RoseMarie Jones; Qihong Zhu; Robert V Considine
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

7.  Meta-analysis of genome-wide linkage studies in BMI and obesity.

Authors:  Catherine L Saunders; Benedetta D Chiodini; Pak Sham; Cathryn M Lewis; Victor Abkevich; Adebowale A Adeyemo; Mariza de Andrade; Rector Arya; Gerald S Berenson; John Blangero; Michael Boehnke; Ingrid B Borecki; Yvon C Chagnon; Wei Chen; Anthony G Comuzzie; Hong-Wen Deng; Ravindranath Duggirala; Mary F Feitosa; Philippe Froguel; Robert L Hanson; Johannes Hebebrand; Patricia Huezo-Dias; Ahmed H Kissebah; Weidong Li; Amy Luke; Lisa J Martin; Matthew Nash; Miina Ohman; Lyle J Palmer; Leena Peltonen; Markus Perola; R Arlen Price; Susan Redline; Sathanur R Srinivasan; Michael P Stern; Steven Stone; Heather Stringham; Stephen Turner; Cisca Wijmenga; David A Collier
Journal:  Obesity (Silver Spring)       Date:  2007-09       Impact factor: 5.002

8.  The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women.

Authors:  K Anderlová; J Kremen; R Dolezalová; J Housová; D Haluzíková; M Kunesová; M Haluzík
Journal:  Physiol Res       Date:  2005-08-05       Impact factor: 1.881

9.  Genetics of Obesity: What have we Learned?

Authors:  Hélène Choquet; David Meyre
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

10.  Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.

Authors:  Eric Ravussin; Steven R Smith; Julie A Mitchell; Reshma Shringarpure; Kevin Shan; Holly Maier; Joy E Koda; Christian Weyer
Journal:  Obesity (Silver Spring)       Date:  2009-06-11       Impact factor: 5.002

View more
  1 in total

1.  Characterization of DNA methylation as well as mico-RNA expression and screening of epigenetic markers in adipogenesis.

Authors:  Yong Zhang; Fancheng Chen; Fangxue Zhang; Xiaowei Huang
Journal:  J Transl Med       Date:  2022-02-15       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.